➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts

Last Updated: July 31, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Sorivudine

Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Sorivudine?

Sorivudine is an investigational drug.

There have been 6 clinical trials for Sorivudine. The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 1997.

The most common disease conditions in clinical trials are Herpes Zoster, Chickenpox, and Rectal Neoplasms. The leading clinical trial sponsors are Bristol-Myers Squibb, M.D. Anderson Cancer Center, and Genentech, Inc.

Recent Clinical Trials for Sorivudine
Study to Compare Efficacy of Topical ARYS-01 (Sorivudine) Cream 3%, Oral Valaciclovir and Combination ARYS-01 Cream 3%/Oral Valaciclovir for Treatment of Herpes Zoster (Shingles)aRigen Pharmaceuticals, Inc.Phase 2
Bevacizumab, Erlotinib, and Capecitabine for Locally Advanced Rectal CancerGenentech, Inc.Phase 1
Bevacizumab, Erlotinib, and Capecitabine for Locally Advanced Rectal CancerM.D. Anderson Cancer CenterPhase 1

See all Sorivudine clinical trials

Clinical Trial Summary for Sorivudine

Top disease conditions for Sorivudine
Top clinical trial sponsors for Sorivudine

See all Sorivudine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.